EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Deciphering the Metabolic Impact and Clinical Relevance of N‐Glycosylation in Colorectal Cancer through Comprehensive Glycoproteomic Profiling

Guobin Liu, Lu Chen, Jingxiang Zhao, Yue Jiang, Yarong Guo, Xiang Mao, Xuelian Ren, Kun Liu, Qi Mei, Qunyi Li, He Huang iD

Advanced Science · 2025

DOI: 10.1002/advs.202415645 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Guobin Liu und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Chemical Biology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Proteomics, Glycoproteins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shanghai Municipal Science and Technology Major Project, Strategic Priority Research Program of the Chinese Academy of Sciences, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC) progression is driven by complex metabolic alterations, including aberrant N‐glycosylation patterns that critically influence tumor development. However, the metabolic and functional roles of N‐glycosylation in CRC remain poorly understood. Herein, comprehensive proteomic and N‐linked intact glycoproteomics analyses are performed on 45 CRC tumors, and normal adjacent tissues (NATs) are matched, identifying 7125 intact N‐glycopeptides from 704 glycoproteins. Through analysis of glycoform expression profiles and structural characteristics, a glycosylation site–protein function association network is constructed to uncover metabolic dysregulation driven by N‐glycosylation in CRC. Moreover, an arithmetic model is developed that integrates N‐glycan expression patterns, which effectively distinguishes tumors from NATs, reflecting metabolic reprogramming in cancer. These findings identify Chloride Channel Accessory 1 (CLCA1) and Olfactomedin 4 (OLFM4) as potential metabolic biomarkers for CRC diagnosis. Immunohistochemistry and Cox regression analyses validated the prognostic power of these markers. Notably, the critical role of specific N‐glycosylation at N196 of Adipocyte plasma membrane‐associated protein (APMAP) is highlighted, a key player in tumor metabolism and CRC progression, providing a potential target for therapeutic intervention. These findings offer valuable insights into the metabolic roles of N‐glycosylation in CRC, advancing biomarker discovery, enhancing metabolic‐based diagnostic precision, and improving personalized treatment strategies targeting cancer metabolism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsProteomicsGlycoproteinsHumansGlycosylationFemaleMaleBiomarkers, TumorMiddle AgedAgedClinical RelevanceGranulocyte Colony-Stimulating Factor

Stichwörter der Autor:innen

clinical relevancecolorectal cancerfunctionsglycoproteomicsintact N‐glycopeptides

Substanzen

GlycoproteinsBiomarkers, TumorOLFM4 protein, humanGranulocyte Colony-Stimulating Factor

Autor:innen und Institutionen

  • State Key Laboratory of Chemical Biology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
  • Department of Pharmacy, Huashan Hospital, Fudan University, Shanghai, 200040, China.
  • School of Life Science and Technology, ShanghaiTech University, Shanghai, 201203, China.
  • Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai, 264117, China.
  • School of Mechanical Engineering and Automation, Northeastern University, Shenyang, 110819, China.
  • Department of Digestive System Oncology, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, 030032, China.

ORCID-Profile: He Huang

Förderung

  • Shanghai Municipal Science and Technology Major Project
  • Strategic Priority Research Program of the Chinese Academy of Sciences
  • National Natural Science Foundation of China
  • Natural Science Foundation of Shanghai
  • Shandong Laboratory Program
  • Natural Science Foundation of Shanghai Municipality

Zitieren

APA

Liu, G., Chen, L., Zhao, J., Jiang, Y., Guo, Y., Mao, X., Ren, X., Liu, K., Mei, Q., Li, Q., & Huang, H. (2025). Deciphering the Metabolic Impact and Clinical Relevance of N‐Glycosylation in Colorectal Cancer through Comprehensive Glycoproteomic Profiling. Advanced Science. https://doi.org/10.1002/advs.202415645

Vancouver

Liu G, Chen L, Zhao J, Jiang Y, Guo Y, Mao X, et al. Deciphering the Metabolic Impact and Clinical Relevance of N‐Glycosylation in Colorectal Cancer through Comprehensive Glycoproteomic Profiling. Advanced Science. 2025. doi:10.1002/advs.202415645

BibTeX
@article{Liu2025,
  author = {Liu, Guobin and Chen, Lu and Zhao, Jingxiang and Jiang, Yue and Guo, Yarong and Mao, Xiang and Ren, Xuelian and Liu, Kun and Mei, Qi and Li, Qunyi and Huang, He},
  title = {Deciphering the Metabolic Impact and Clinical Relevance of N‐Glycosylation in Colorectal Cancer through Comprehensive Glycoproteomic Profiling},
  journal = {Advanced Science},
  year = {2025},
  doi = {10.1002/advs.202415645}
}
Kostenlos starten →